EcoDrugPlus

Vascular Endothelial Growth Factor Receptor 3-Like

Ensembl ID : ENSNBRG00000014714
Gene Symbol: LOC102787200
3 Cross references
193 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSNBRG00000019438
Gene Symbol: VDR
3 Cross references
388 Possible Orthologues:

Vitamin D3 Receptor B-Like

Ensembl ID : ENSNBRG00000015262
Gene Symbol: LOC102787922
3 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like

Ensembl ID : ENSNBRG00000013244
Gene Symbol: LOC102779891
3 Cross references
190 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1c-Like

Ensembl ID : ENSNBRG00000004240
Gene Symbol: LOC102778835
3 Cross references
213 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1d-Like

Ensembl ID : ENSNBRG00000003082
Gene Symbol: LOC102796617
3 Cross references
211 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1f-Like

Ensembl ID : ENSNBRG00000009240
Gene Symbol: LOC102782772
3 Cross references
177 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-1-Like

Ensembl ID : ENSNBRG00000020208
Gene Symbol: LOC102800090
3 Cross references
209 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-2-Like

Ensembl ID : ENSNBRG00000015264
Gene Symbol: LOC102799424
3 Cross references
201 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-4-Like

Ensembl ID : ENSNBRG00000022952
Gene Symbol: LOC102792394
3 Cross references
196 Possible Orthologues:

Voltage-Dependent N-Type Calcium Channel Subunit Alpha-1b-Like

Ensembl ID : ENSNBRG00000010779
Gene Symbol: LOC102778062
3 Cross references
219 Possible Orthologues:

Voltage-Dependent P/q-Type Calcium Channel Subunit Alpha-1a-Like

Ensembl ID : ENSNBRG00000024372
Gene Symbol: LOC102775886
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).